McKesson Corporation reported stronger-than-expected revenues in Q1 2027, driven by growth in specialty pharmacy services and Prescription Technology Solutions. The company continues executing its strategy to separate the Medical-Surgical Solutions segment and expand technology-enabled offerings that integrate across healthcare providers and manufacturers. While operational efficiency gains from AI and automation underpin performance, competitive pressures and liquidity constraints remain risks to monitor.